Wird geladen...
Biologics in inflammatory bowel disease: what are the data?
BACKGROUND: Over the last decade, biologics have gained an important place for the treatment of moderate to severe inflammatory bowel disease (IBD), and many randomized control trials have evaluated their efficacy. AIM: The goal of this review is to analyze the results of these trials and to highlig...
Gespeichert in:
| Veröffentlicht in: | United European Gastroenterol J |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4625751/ https://ncbi.nlm.nih.gov/pubmed/26535119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615590302 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|